Response
According to the RECIST criteria, 20 participants demonstrated an ORR (26.7% [95% CI, 16.7–36.7%]) out of 75 patients in the GV1001 group and 20 patients (27.4% [95% CI, 17.2–37.6%]) in the control group, and all were partial response (PR) (Table 